Results 221 to 230 of about 77,920 (253)

Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial

Lancet, The, 2019
Désirée M Van Der Heijde, Atul Deodhar, Mrcp, Filip E Van Den Bosch   +2 more
exaly  

ANKYLOSING SPONDYLITIS

The Lancet, 1949
openaire   +1 more source

Ankylosing Spondylitis

2008
Liebscher, T, Min, K, Boos, N
openaire   +2 more sources

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial

Lancet, The, 2018
Désirée M Van Der Heijde, Xenofon Baraliakos, Lianne S Gensler   +2 more
exaly  

Ankylosing spondylitis

Postgraduate Medicine, 1982
openaire   +2 more sources

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

Lancet, The, 2002
Juergen Braun, Matthias Schneider
exaly  

Rheumatoid (Ankylosing) Spondylitis

Medical Clinics of North America, 1961
W M, MIKKELSEN, I F, DUFF
openaire   +2 more sources

Impact of sex on inheritance of ankylosing spondylitis: a cohort study

Lancet, The, 1999
Sinead Brophy
exaly  

Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci

Nature Genetics, 2010
John D Reveille, Paul Leo, Xiaodong Zhou
exaly  

Ankylosing Spondylitis and Axial Spondyloarthritis

New England Journal of Medicine, 2016
Avneesh Chhabra, Robert A Colbert
exaly